CAAS Capital Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-11,500
Closed -$1.15M 483
2023
Q3
$1.11M Buy
+11,500
New +$1.21M 0.07% 252
2023
Q2
Sell
-6,913
Closed -$737K 670
2023
Q1
$700K Buy
+6,913
New +$730K 0.04% 344
2021
Q3
Sell
-4,351
Closed -$534K 925
2021
Q2
$504K Buy
+4,351
New +$507K 0.01% 730
2020
Q4
Sell
-14,250
Closed -$1.55M 815
2020
Q3
$1.55M Sell
14,250
-33,350
-70% -$3.38M 0.04% 288
2020
Q2
$4.35M Buy
+47,600
New +$4.3M 0.14% 143

Other funds holding ABT

CAAS Capital Management's ABT Position: Q4 2023 in Review

CAAS Capital Management sold out of Abbott (ABT) in Q4 2023, closing a stake of 11,500 shares — an estimated $1.15M sold.

CAAS Capital Management first reported a position in ABT in Q2 2020 and held it in 5 quarters. The position peaked at $4.35M in Q2 2020. 2,886 funds tracked by Wall St. Rank hold ABT as of Q4 2023.

  • CAAS Capital Management reported no remaining Abbott position as of Q4 2023 after selling out during the quarter.
  • CAAS Capital Management sold 11,500 Abbott shares in Q4 2023, an estimated $1.15M.
  • CAAS Capital Management first reported a position in Abbott in Q2 2020 and held it in 5 quarters.
  • CAAS Capital Management's Abbott position peaked at $4.35M in Q2 2020.
  • 2,886 funds tracked by Wall St. Rank held Abbott as of Q4 2023.

Based on CAAS Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.